ArticleJournal of cellular and molecular medicine2022

Establishment of a five-enzalutamide-resistance-related-gene-based classifier for recurrence-free survival predicting of prostate cancer.

Jing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.